Cerebral serotonin transporter binding is inversely related to body mass index

NeuroImage

Volumn 52, Issue 1, 2010, Pages 284-289

  Erritzoe, D ^a,b   Frokjaer, V G ^a,b   Haahr, M T ^a,b   Kalbitzer, J ^a,b   Svarer, C ^a,b   Holst, K K ^a,b   Hansen, D L ^c   Jernigan, T L ^b,c,d   Lehel, S ^e   Knudsen, G M ^a,b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Center for Integrated Molecular Brain Imaging   (Denmark)

^c HVIDOVRE HOSPITAL   (Denmark)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Rigshospitalet   (Denmark)

Author keywords

Imaging; Obesity; PET; Serotonin; Serotonin transporter

Indexed keywords

RADIOLIGAND; SEROTONIN TRANSPORTER; AGINACTIN PROTEIN, DICTYOSTELIUM; BENZYLAMINE DERIVATIVE; CARBON; N,N-DIMETHYL-2-(2-AMINO-4-CYANOPHENYLTHIO)BENZYLAMINE; PROTOZOAL PROTEIN; SLC6A4 PROTEIN, HUMAN;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; BRAIN CORTEX; BRAIN REGION; CORRELATION ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN BINDING; SMOKING; VOLUNTEER; BRAIN; DRINKING BEHAVIOR; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; PHOTOSTIMULATION; SCINTISCANNING; SEXUAL DEVELOPMENT; SIGNAL PROCESSING; STATISTICAL MODEL;

ADULT; ALCOHOL DRINKING; BENZYLAMINES; BODY MASS INDEX; BRAIN; CARBON RADIOISOTOPES; FEMALE; HUMANS; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBESITY; PHOTIC STIMULATION; POSITRON-EMISSION TOMOGRAPHY; PROTOZOAN PROTEINS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; SEX CHARACTERISTICS; SIGNAL PROCESSING, COMPUTER-ASSISTED; SMOKING;

EID: 77953574649     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.03.086     Document Type: Article

References (63)

1. Adams K.H., Pinborg L.H., et al. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables. Neuroimage 2004, 21(3):1105-1113.
2. Bever K.A., Perry P.J. Dexfenfluramine hydrochloride: an anorexigenic agent. Am. J. Health Syst. Pharm. 1997, 54(18):2059-2072.
3. Blundell J.E. Serotonin and appetite. Neuropharmacology 1984, 23(12B):1537-1551.
4. Breisch S.T., Zemlan F.P., et al. Hyperphagia and obesity following serotonin depletion by intraventricular p-chlorophenylalanine. Science 1976, 192(4237):382-385.
5. Cahir M., Ardis T., et al. Acute and chronic tryptophan depletion differentially regulate central 5-HT1A and 5-HT 2A receptor binding in the rat. Psychopharmacology (Berl) 2007, 190(4):497-506.
6. Casanova R., Srikanth R., et al. Biological parametric mapping: a statistical toolbox for multimodality brain image analysis. Neuroimage 2007, 34(1):137-143.
7. Derogatis L.R. Symptom Checklist-90-R. Administration, scoring and procedures manual 1994, National Computer Systems 1994, Minneapolis, Minnesota. 3rd edition.
8. Dewar K.M., Grondin L., et al. [3H]paroxetine binding and serotonin content of rat cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region following p-chlorophenylalanine and p-chloroamphetamine treatment. J. Neurochem. 1992, 58(1):250-257.
9. Erritzoe D., Frokjaer V.G., et al. Brain serotonin 2A receptor binding: relations to body mass index, tobacco and alcohol use. Neuroimage 2009, 46(1):23-30.
10. Erritzoe D., Holst K., Frokjaer V.G., Licht C.L., Kalbitzer J., Nielsen F.A., Svarer C., Madsen J., Knudsen G. A nonlinear relationship between cerebral serotonin transporter and 5-HT(2A) receptor binding: an in vivo molecular imaging study in humans. J. Neurosci. 2010, 30:3391-3397.
11. Feinn R., Nellissery M., et al. Meta-analysis of the association of a functional serotonin transporter promoter polymorphism with alcohol dependence. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005, 133B(1):79-84.
12. Fernstrom J.D., Faller D.V., et al. Acute reduction of brain serotonin and 5-HIAA following food consumption: correlation with the ratio of serum tryptophan to the sum of competing amino acids. J. Neural. Transm. 1975, 36(2):113-121.
13. Frankle W.G., Slifstein M., et al. Estimation of serotonin transporter parameters with 11C-DASB in healthy humans: reproducibility and comparison of methods. J. Nucl. Med. 2006, 47(5):815-826.
14. Frokjaer V.G., Vinberg M., et al. High familial risk for mood disorder is associated with low dorsolateral prefrontal cortex serotonin transporter binding. Neuroimage 2009, 46(2):360-366.
15. Fuemmeler B.F., Agurs-Collins T.D., et al. Genes implicated in serotonergic and dopaminergic functioning predict BMI categories. Obesity (Silver Spring) 2008, 16(2):348-355.
16. Ginovart N., Wilson A.A., et al. Positron emission tomography quantification of [ 11 C]-DASB binding to the human serotonin transporter: modeling strategies. J. Cereb. Blood Flow Metab. 2001, 21(11):1342-1353.
17. Halford J.C., Harrold J.A., et al. Serotonin (5-HT) drugs: effects on appetite expression and use for the treatment of obesity. Curr. Drug Targets 2005, 6(2):201-213.
18. Hansen, H.S., Mortensen, E.L., 2004. NEO-PI-R, manual - klinisk: Hansen, H.S. & Mortensen E.L. Dokumentation for den danske udgave af NEO-PI-R og NEO-PI-R Kort Version 1st edi. Dansk Psykologisk Forlag, Copenhagen, Denmark.
19. Heinz A., Goldman D., et al. Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence. Psychopharmacology (Berl) 2004, 174(4):561-570.
20. Hoerl H., Kennard R. Ridge regression: biased estimation for nonorthogonal problems. Technometrics 1970, 12(5):55-67.
21. Holmes A., Murphy D.L., Crawley J.N. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl) 2002, 161:160-167.
22. Houle S., Ginovart N., et al. Imaging the serotonin transproter with positron emission tomomgraphy: initial human studies with [11C]DAPP and [11C]DASB. Eur. J. Nucl. Med. 2000, 27(11):1719-1722.
23. Houle S., Ginovart N., et al. Imaging the serotonin transporter with positron emission tomography: initial human studies with [11C]DAPP and [11C]DASB. Eur. J. Nucl. Med. 2000, 27(11):1719-1722.
24. Ichise M., Liow J.S., et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J. Cereb. Blood Flow Metab. 2003, 23(9):1096-1112.
25. Innis R.B., et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J. Cereb. Blood Flow Metab. 2007, 27:1533-1539.
26. Johnson B.A. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem. Pharmacol. 2008, 75(1):34-56.
27. Jovanovic H., Karlsson P., et al. 5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET. Psychiatry Res. 2009, 172(1):31-37.
28. Jovicich J., Czanner S., et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage 2006, 30(2):436-443.
29. Kalbitzer J., Frokjaer V.G., et al. The personality trait openness is related to cerebral 5-HTT levels. Neuroimage 2009, 45(2):280-285.
30. Kim J.S., Ichise M., et al. PET imaging of serotonin transporters with [11C]DASB: test-retest reproducibility using a multilinear reference tissue parametric imaging method. J. Nucl. Med. 2006, 47(2):208-214.
31. Kish S.J., Furukawa Y., et al. Regional distribution of serotonin transporter protein in postmortem human brain: is the cerebellum a SERT-free brain region?. Nucl. Med. Biol. 2005, 32(2):123-128.
32. Koskela A.K., Kaurijoki S., et al. Serotonin transporter binding and acquired obesity-an imaging study of monozygotic twin pairs. Physiol. Behav. 2008, 93(4-5):724-732.
33. Kuikka J.T., Tammela L., et al. Reduced serotonin transporter binding in binge eating women. Psychopharmacology (Berl) 2001, 155(3):310-314.
34. Leibowitz S.F., Alexander J.T. Hypothalamic serotonin in control of eating behavior, meal size, and body weight. Biol. Psychiatry 1998, 44(9):851-864.
35. Lopes de Souza S., Orozco-Solis R., Grit I., Manhaes de Castro R., Bolanos-Jimenez F. Perinatal protein restriction reduces the inhibitory action of serotonin on food intake. Eur. J. Neurosci. 2008, 27:1400-1408.
36. Matsumoto R. Inverse correlation between body mass index and serotonin transporter in human brain: A [11C]DASB PET study. NeuroImage 2008, 41(Suppl 2):T161. (Abstract).
37. Meyer J.H., Wilson A.A., et al. Occupancy of serotonin transporters by paroxetine and citalopram during treatment of depression: a [(11)C]DASB PET imaging study. Am. J. Psychiatry 2001, 158(11):1843-1849.
38. Miner L.H., Schroeter S., et al. Ultrastructural localization of the serotonin transporter in superficial and deep layers of the rat prelimbic prefrontal cortex and its spatial relationship to dopamine terminals. J. Comp. Neurol. 2000, 427(2):220-234.
39. Molarius A., Seidell J.C. Selection of anthropometric indicators for classification of abdominal fatness-a critical review. Int. J. Obes. Relat. Metab. Disord. 1998, 22(8):719-727.
40. Murphy D.L., Lesch K.P. Targeting the murine serotonin transporter: insights into human neurobiology. Nat. Rev. Neurosci. 2008, 9(2):85-96.
41. Noach E.L. Appetite regulation by serotoninergic mechanisms and effects of d-fenfluramine. Neth. J. Med. 1994, 45(3):123-133.
42. Olausson P., Engel J.A., et al. Involvement of serotonin in nicotine dependence: processes relevant to positive and negative regulation of drug intake. Pharmacol. Biochem. Behav. 2002, 71(4):757-771.
43. Olsen L.R., Mortensen E.L., et al. Mental distress in the Danish general population. Acta Psychiatr. Scand. 2006, 113(6):477-484.
44. Praschak-Rieder N., Kennedy J., et al. Novel 5-HTTLPR allele associates with higher serotonin transporter binding in putamen: a [(11)C] DASB positron emission tomography study. Biol. Psychiatry 2007, 62(4):327-331.
45. Praschak-Rieder N., Willeit M., et al. Seasonal variation in human brain serotonin transporter binding. Arch. Gen. Psychiatry 2008, 65(9):1072-1078.
46. Rattray M., Baldessari S., et al. p-Chlorphenylalanine changes serotonin transporter mRNA levels and expression of the gene product. J. Neurochem. 1996, 67(2):463-472.
47. Reimold M., Smolka M.N., et al. Midbrain serotonin transporter binding potential measured with [11C]DASB is affected by serotonin transporter genotype. J. Neural. Transm. 2007, 114(5):635-639.
48. Roth B.L., Berry S.A., et al. Serotonin 5-HT2A receptors: molecular biology and mechanisms of regulation. Crit. Rev. Neurobiol. 1998, 12(4):319-338.
49. Rothman R.B., Jayanthi S., et al. High-dose fenfluramine administration decreases serotonin transporter binding, but not serotonin transporter protein levels, in rat forebrain. Synapse 2003, 50(3):233-239.
50. Saller C.F., Stricker E.M. Hyperphagia and increased growth in rats after intraventricular injection of 5, 7-dihydroxytryptamine. Science 1976, 192(4237):385-387.
51. Simansky K.J. Serotonergic control of the organization of feeding and satiety. Behav. Brain Res. 1996, 73(1-2):37-42.
52. Sled J.G., Zijdenbos A.P., et al. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17(1):87-97.
53. Smith K.A., Fairburn C.G., et al. Symptomatic relapse in bulimia nervosa following acute tryptophan depletion. Arch. Gen. Psychiatry 1999, 56(2):171-176.
54. Sookoian S., Gemma C., et al. Short allele of serotonin transporter gene promoter is a risk factor for obesity in adolescents. Obesity (Silver Spring) 2007, 15(2):271-276.
55. Strombom U., Krotkiewski M., et al. The concentrations of monoamine metabolites and neuropeptides in the cerebrospinal fluid of obese women with different body fat distribution. Int. J. Obes. Relat. Metab. Disord. 1996, 20(4):361-368.
56. Svarer C., Madsen K., et al. MR-based automatic delineation of volumes of interest in human brain PET images using probability maps. Neuroimage 2005, 24(4):969-979.
57. Tammela L.I., Rissanen A., et al. Treatment improves serotonin transporter binding and reduces binge eating. Psychopharmacology (Berl) 2003, 170(1):89-93.
58. Waldbillig R.J., Bartness T.J., et al. Increased food intake, body weight, and adiposity in rats after regional neurochemical depletion of serotonin. J. Comp. Physiol. Psychol. 1981, 95(3):391-405.
59. Warden S.J., Robling A.G., Sanders M.S., Bliziotes M.M., Turner C.H. Inhibition of the serotonin (5-hydroxytryptamine) transporter reduces bone accrual during growth. Endocrinology 2005, 146:685-693.
60. Weltzin T.E., Fernstrom M.H., et al. Serotonin and bulimia nervosa. Nutr. Rev. 1994, 52(12):399-408.
61. Weltzin T.E., Fernstrom M.H., et al. Acute tryptophan depletion and increased food intake and irritability in bulimia nervosa. Am. J. Psychiatry 1995, 152(11):1668-1671.
62. Woods R.P., Cherry S.R., et al. Rapid automated algorithm for aligning and reslicing PET images. J. Comput. Assist. Tomogr. 1992, 16(4):620-633.
63. Wurtman R.J., Wurtman J.J. Brain serotonin, carbohydrate-craving, obesity and depression. Obes. Res. 1995, 3(Suppl 4):477S-480S.